Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer
Clinical trial NCT02965976 · COMPLETED
Trial details
- NCT number
- NCT02965976
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2022-01-28
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.